Nymox Pharmaceutical Corp
(NASDAQ : NYMX)

( )
NYMX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABMDABIOMED, Inc.
-2.51%427.293.3%$598.54m
ISRGIntuitive Surgical, Inc.
-0.80%483.212.4%$420.67m
MDTMedtronic PLC
0.58%86.800.6%$414.41m
ALGNAlign Technology, Inc.
-1.76%353.276.3%$350.51m
SYKStryker Corporation
1.28%171.991.3%$342.59m
BSXBoston Scientific Corporation
1.49%32.631.1%$323.32m
ABTAbbott Laboratories
0.28%61.920.8%$312.94m
BDXBecton, Dickinson and Company
1.85%237.561.1%$282.08m
TMOThermo Fisher Scientific Inc.
1.09%208.781.0%$258.62m
BAXBaxter International Inc.
0.79%74.321.7%$239.57m
EWEdwards Lifesciences Corporation
0.41%152.801.2%$200.43m
COOCooper Companies, Inc.
1.39%237.242.2%$134.05m
XRAYDENTSPLY International Inc.
0.85%44.953.0%$132.85m
WATWaters Corporation
0.37%193.713.4%$132.79m
ZBHZimmer Biomet Holdings, Inc.
0.20%111.731.7%$105.21m

Company Profile

Nymox Pharmaceutical Corp.operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.